| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6387383 | LEO PHARMA AS | Topical low-viscosity gel composition |
Aug, 2020
(3 years ago) | |
Desonate is owned by Leo Pharma As.
Desonate contains Desonide.
Desonate has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Desonate are:
- US6387383
Desonate was authorised for market use on 20 October, 2006.
Desonate is available in gel;topical dosage forms.
Desonate can be used as desonate gel is indicated for the treatment of mild to moderate atopic dermatitis in patients 3 months of age and older.
The generics of Desonate are possible to be released after 03 August, 2020.
Drugs and Companies using DESONIDE ingredient
Market Authorisation Date: 20 October, 2006
Treatment: Desonate gel is indicated for the treatment of mild to moderate atopic dermatitis in patients 3 months of age and older
Dosage: GEL;TOPICAL
DESONATE family patents
